TrialAtherosclerosis1999

Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease.

J R Schaefer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.